Visit the Emblem Corp Investor Dashboard and stay up to date with data-driven, fact based due diligence for active traders and investors.
Emblem Bolsters Medical Division to Support Growth and Product Innovation with Appointment of Wayne Kreppner as President
TORONTO, Oct. 11, 2018 (GLOBE NEWSWIRE) — Emblem Corp. (TSXV: EMC, OTCQX:EMMBF) (“Emblem” or the “Company”) today announced additional leadership and operational resources to support the rapid growth of its medical division and associated new product innovations. Emblem Director and current Medical Division President, John H. Stewart, welcomes Wayne Kreppner to the Company as the Division’s new President. Mr. Stewart will oversee the Division in an advisory capacity and will remain a member of Emblem’s Board of Directors. Mr. Kreppner will begin November 1, 2018. The appointment of Mr. Kreppner is